ALEC
NASDAQ · Biotechnology
Alector Inc
$2.63
+0.10 (+3.95%)
Financial Highlights (FY 2026)
Revenue
31.24M
Net Income
-212,223,311
Gross Margin
—
Profit Margin
-679.2%
Rev Growth
-46.0%
D/E Ratio
0.32
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | — | — | 64.5% | 64.5% |
| Operating Margin | -741.3% | -667.2% | 8.6% | 8.1% |
| Profit Margin | -679.2% | -645.2% | 9.4% | 7.0% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 31.24M | 57.85M | 87.33M | 87.17M |
| Gross Profit | — | — | 56.35M | 56.25M |
| Operating Income | -231,611,364 | -385,947,468 | 7.53M | 7.07M |
| Net Income | -212,223,311 | -353,640,029 | 8.20M | 6.12M |
| Gross Margin | — | — | 64.5% | 64.5% |
| Operating Margin | -741.3% | -667.2% | 8.6% | 8.1% |
| Profit Margin | -679.2% | -645.2% | 9.4% | 7.0% |
| Rev Growth | -46.0% | -46.0% | +6.5% | -4.4% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 40.77M | 40.77M | 37.32M | 37.66M |
| Total Equity | 128.98M | 128.98M | 74.11M | 65.78M |
| D/E Ratio | 0.32 | 0.32 | 0.50 | 0.57 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | -223,142,634 | -392,493,061 | 10.19M | 12.10M |
| Free Cash Flow | — | — | 6.96M | 5.08M |